Published Technical Disclosure Archive

Synergistic Ophthalmic Diagnostic Systems

Publication ID: 24-11857255_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Ophthalmic Diagnostic Systems,” Published Technical Disclosure No. 24-11857255_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857255_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,255.

Summary of the Inventive Concept

This inventive concept integrates an ophthalmic apparatus with cutting-edge technologies such as AI, IoT, blockchain, and new materials to create a more powerful and efficient diagnostic system for ophthalmic diseases.

Background and Problem Solved

The original ophthalmic apparatus patent has limitations in terms of data analysis, storage, and sharing. This new inventive concept addresses these limitations by incorporating advanced technologies to enhance diagnostic accuracy, security, and accessibility.

Detailed Description of the Inventive Concept

The synergistic system combines an ophthalmic apparatus with an artificial intelligence module for advanced image analysis and diagnostic recommendations. It also integrates with a cloud-based server for secure data storage and sharing, utilizing blockchain technology for secure data management. Furthermore, the system can be connected to an IoT network for remote monitoring and analysis. Additionally, the system can generate 3D models of the target part for personalized treatment planning.

Novelty and Inventive Step

The new claims introduce novel combinations of the ophthalmic apparatus with AI, IoT, blockchain, and new materials, providing a significant improvement over the original patent. The inventive step lies in the synergistic integration of these technologies to create a more powerful and efficient diagnostic system.

Alternative Embodiments and Variations

Alternative embodiments may include integrating the ophthalmic apparatus with other AI algorithms, using different blockchain protocols, or incorporating new materials for improved image capture. Variations may include adapting the system for use in different medical specialties or developing portable versions for remote diagnosis.

Potential Commercial Applications and Market

The synergistic ophthalmic diagnostic system has significant commercial potential in the healthcare industry, particularly in ophthalmology and optometry. It can also be applied in telemedicine, medical research, and pharmaceutical industries, offering a competitive advantage in terms of diagnostic accuracy and efficiency.

CPC Classifications

SectionClassGroup
A A61 A61B3/0025
A A61 A61B3/0041
A A61 A61B3/102

Field of Art

Ophthalmic diagnostic imaging systems, specifically involving advanced image capture and analysis techniques for medical diagnostics, requiring expertise in medical imaging, computer vision, and biomedical engineering

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical imaging specialist with advanced knowledge of optical systems, image processing algorithms, medical diagnostic technologies, and interdisciplinary technology integration

Obviousness Rationale

A PHOSITA would recognize that integrating artificial intelligence, cloud computing, and IoT technologies with existing ophthalmic imaging apparatus represents a predictable technological evolution. The source patent's foundational imaging methodology provides a clear technical framework for extending diagnostic capabilities through advanced computational techniques. These integrations represent logical extensions of existing medical imaging technological trends.

Obvious Combinations & Variations

Source Patent Element
Image capturing unit for capturing target parts of a subject eye
PTD Variation
Adding AI-powered image analysis module for diagnostic recommendations
Obviousness Reasoning
Applying machine learning to medical imaging is a known technique with predictable results in enhancing diagnostic accuracy
Source Patent Element
Processor and memory for image processing
PTD Variation
Integrating blockchain-based secure data storage and transmission
Obviousness Reasoning
Implementing secure data management techniques is a standard design choice in medical technology systems
Source Patent Element
Image capturing of specific eye regions
PTD Variation
Generating 3D models for personalized treatment planning
Obviousness Reasoning
Transforming 2D medical images into 3D models is a well-established technique in medical imaging with predictable technological progression
Source Patent Element
Ophthalmic apparatus for capturing eye images
PTD Variation
Connecting to IoT network for remote monitoring and analysis
Obviousness Reasoning
Integrating medical devices with networked communication systems represents a standard technological enhancement with foreseeable implementation
Source Patent Element
Image processing capabilities
PTD Variation
Cloud-based server integration for advanced computational analysis
Obviousness Reasoning
Leveraging cloud computing for medical image processing is a known technique with expected performance improvements
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857255 and the technological context of ophthalmic diagnostic systems, the variations disclosed herein would be considered obvious to a Person Having Ordinary Skill In The Art. The integration of AI, blockchain, IoT, and cloud computing technologies represents predictable extensions of existing medical imaging methodologies, rendering potential patent claims obvious and unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,255
TitleOphthalmic apparatus
Assignee(s)Tomey Corporation